AXREM appoints convenors for key SFGs
AXREM has appointed new convenors to three of its special focus groups (SFG). Kayleigh Patterson is the first convenor for the association’s recently established digital pathology SFG, while David Kynaston takes over from Daniel Baines to convene the radiotherapy SFG and Chris Lawman succeeds David Britton in convening the patient monitoring SFG.
Product and release manager, digital pathology UK, Fujifilm Healthcare UK, Patterson has an extensive background in digital pathology with experience of successful implementation of the Fujifilm solution for nearly six years. She also has more than 12 years’ experience in an NHS histology laboratory with a focus on implementation of digital pathology for clinical diagnostic reporting. Patterson was instrumental in the first digital pathology implementation in the UK.
Kynaston started his career in MedTech eight years ago at Philips as an imaging account manager, covering a range of diagnostic and interventional equipment as well as its radiation oncology portfolio. A number of years later he took up his current role at Brainlab as UK and Ireland manager for the radiation oncology business, which has focused his knowledge to the specific area of radiotherapy.
AXREM’s patient monitoring SFG was established in 2023, publishing a patient monitoring manifesto in 2024. GE HealthCare senior modality leader patient monitoring and connectivity, Lawman has been with GE for more than 27 years, holding various roles in the service and sales side of the business. Throughout his career, his focus has been patient monitoring and he has deep knowledge of networking, connectivity and interoperability. For the last nine years he has been an integral part of the patient care solutions management team and will be expanding his role to cover the whole of northern Europe.
Picture: Kayleigh Patterson, David Kynaston and Chris Lawman.
Read this report on page 14 of the May 2025 issue of RAD Magazine.
The content on this page is provided by the individuals concerned and does not represent the views or opinions of RAD Magazine.
